Search Results - "Amin, Sam"
-
1
Treatment Guidelines for Rare, Early-Onset, Treatment-Resistant Epileptic Conditions: A Literature Review on Dravet Syndrome, Lennox-Gastaut Syndrome and CDKL5 Deficiency Disorder
Published in Frontiers in neurology (25-10-2021)“…Dravet syndrome (DS), Lennox-Gastaut syndrome (LGS) and CDKL5 deficiency disorder (CDD) are rare epileptic conditions, characterised by drug-resistant…”
Get full text
Journal Article -
2
Impact of facial angiofibromas in tuberous sclerosis complex and reported efficacy of available treatments
Published in Frontiers in medicine (29-08-2022)“…Tuberous Sclerosis Complex (TSC) is a genetic condition which leads to a loss of inhibition of cellular growth. Facial angiofibromas (FAs) are hamartomatous…”
Get full text
Journal Article -
3
International Consensus Recommendations for the Assessment and Management of Individuals With CDKL5 Deficiency Disorder
Published in Frontiers in neurology (20-06-2022)“…CDKL5 Deficiency Disorder (CDD) is a rare, X-linked dominant condition that causes a developmental and epileptic encephalopathy (DEE). The incidence is between…”
Get full text
Journal Article -
4
The metformin in tuberous sclerosis (MiTS) study: A randomised double-blind placebo-controlled trial
Published in EClinicalMedicine (01-02-2021)“…Tuberous Sclerosis Complex (TSC) is a genetic disorder characterised by the development of benign tumours secondary to loss of inhibitory regulation of the…”
Get full text
Journal Article -
5
Rare epilepsy treatment: What is on the gene‐code lottery list?
Published in Developmental medicine and child neurology (01-01-2024)Get full text
Journal Article -
6
Forewords
Published in Developmental medicine and child neurology (01-01-2024)Get full text
Journal Article -
7
Providing quality care for people with CDKL5 deficiency disorder: A European expert panel opinion on the patient journey
Published in Epilepsia open (01-06-2024)“…Cyclin‐dependent kinase‐like 5 (CDKL5) deficiency disorder (CDD) is a developmental and epileptic encephalopathy caused by variants in the CDKL5 gene. The…”
Get full text
Journal Article -
8
The outcome of surgical management of subependymal giant cell astrocytoma in tuberous sclerosis complex
Published in European journal of paediatric neurology (01-01-2013)“…Abstract Objectives The indications for surgery and outcomes of patients who underwent surgical removal of subependymal giant cell astrocytomas (SEGAs) in our…”
Get full text
Journal Article -
9
Response to updated clinical recommendations for the management of tuberous sclerosis complex associated epilepsy
Published in European journal of paediatric neurology (01-03-2024)Get full text
Journal Article -
10
The journey of metformin from glycaemic control to mTOR inhibition and the suppression of tumour growth
Published in British journal of clinical pharmacology (01-01-2019)“…Our knowledge of the effect of metformin on human health is increasing. In addition to its ability to improve the control of hyperglycaemia, metformin has been…”
Get full text
Journal Article -
11
Causes of mortality in individuals with tuberous sclerosis complex
Published in Developmental medicine and child neurology (01-06-2017)“…Aim The causes of death in patients with tuberous sclerosis complex (TSC) have rarely been studied, with only one published account, which was reported from…”
Get full text
Journal Article -
12
Effect of Concomitant Antiseizure Medications on the Safety and Efficacy of Ganaxolone for the Treatment of Seizures Associated with CDKL5 Deficiency Disorder (CDD): Findings from the Phase 3 MARIGOLD Study (P8-1.006)
Published in Neurology (09-04-2024)“…Abstract only…”
Get full text
Journal Article -
13
Growth patterns in individuals with CDKL5 deficiency disorder
Published in Developmental medicine and child neurology (01-04-2024)“…Aim To compare growth in individuals with cyclin‐dependent kinase‐like 5 (CDKL5) deficiency disorder with population norms and to investigate the effect of…”
Get full text
Journal Article -
14
99 Opportunities to improve screening programmes identifying patients with aromatic L-amino acid decarboxylase deficiency (AADCd) in the UK
Published in Archives of disease in childhood (01-07-2023)“…ObjectiveAromatic L-amino acid decarboxylase deficiency (AADCd) is a rare neurometabolic disorder resulting from variants in the dopa decarboxylase (DDC) gene…”
Get full text
Journal Article -
15
194 Outcomes for patients with cerebral palsy and tracheostomy: use of a novel method to investigate rare conditions and procedures
Published in Archives of disease in childhood (01-07-2023)“…ObjectiveIn a recent review of life expectancy for those with severe impairment with cerebral palsy (CP), Rosenthal’s conclusions stated, ‘tracheostomies…”
Get full text
Journal Article -
16
-
17
Ganaxolone Significantly Reduces Major Motor Seizures Associated with CDKL5 Deficiency Disorder: A Randomized, Double-blind, Placebo-Controlled Phase 3 Study (S13.009)
Published in Neurology (03-05-2022)“…Abstract only…”
Get full text
Journal Article -
18
Quality of life in patients with Tuberous Sclerosis Complex (TSC)
Published in European journal of paediatric neurology (01-11-2019)“…The quality of life (QoL) of patients with Tuberous Sclerosis Complex (TSC) has not been studied before. We aimed to investigate the impact of the disease…”
Get full text
Journal Article -
19
Consensus recommendations for the assessment and management of idiopathic intracranial hypertension in children and young people
Published in Archives of disease in childhood (01-08-2024)“…BackgroundIdiopathic intracranial hypertension (IIH) is a potentially disabling condition. There is a lack of evidence and national guidance on how to diagnose…”
Get full text
Journal Article -
20
Pharmacological management of abnormal tone and movement in cerebral palsy
Published in Archives of disease in childhood (01-08-2019)“…BackgroundThe evidence base to guide the pharmacological management of tone and abnormal movements in cerebral palsy (CP) is limited, as is an understanding of…”
Get full text
Journal Article